Search

everythinglearnresearchcommunity

for

Search:↓

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

A deletion in the CDH3 gene causes a rare disorder with short hair and vision loss.

A genetic mutation in the LIPH gene causes a rare hair disorder with sparse, curly hair.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

KeraGLO improves skin and hair health.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

ATP6AP1‐CDG can cause hearing loss, hair loss, and protein issues, even in female carriers.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Hoyeraal-Hreidarsson syndrome in infants causes severe gastrointestinal issues.

Consider amyloidosis in patients with specific nail changes and check for systemic issues.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

Frontal fibrosing alopecia is a complex condition with no definitive treatment.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Two enzyme defects in biotin metabolism cause severe skin, hair, and metabolic issues.

Fibrosis causes loss of important fat cells, affecting tissue function.

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.